BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Withdrawing funds during index fund rebalance aims to support regular income with tax efficiency. This intro covers sequence and withdrawal choices.
22,112 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
As Congress let enhanced marketplace tax credits lapse, buyers are increasingly eyeing cheaper, alternative health pl...
AMD jumps 8% mid-session as quarterly results highlight data-center momentum, prompting questions about whether it is...
XRP's price stays below $1.40 even as CME-listed futures surpass $63 billion in notional in their first year. Traders...
The White House rolled back Biden-era refrigerant limits affecting grocery stores and HVAC equipment, saying it will ...
Sara Holtz, chief marketing officer at Optimal Blue, outlines a leadership playbook that uses AI to sharpen decision-...
Litecoin has stood the crypto test of time. This guide explains why litecoin been around since 2011 matters today, wh...
Johnson & Johnson and AbbVie report strong Q1 2026 results, showcasing two contrasting growth paths as biosimilar cha...
Two leading travel platforms, Booking Holdings and Airbnb, each chart different revenue paths. This article breaks do...
As markets digest AI hype, Synopsys faces a potential growth trap: strong licensing revenue amid squeezed margins and...
Webull defied flat profits with rapid top‑line growth in Q1 2026, but costs rose sharply and regulatory headwinds loo...
This article breaks down the expected path for synopsys (snps) 2026 earnings, focusing on AI design driver demand, li...